Epstein-Barr virus (EBV) in endemic Burkitt's lymphoma: molecular analysis of primary tumor tissue
- PMID: 9454768
Epstein-Barr virus (EBV) in endemic Burkitt's lymphoma: molecular analysis of primary tumor tissue
Erratum in
- Blood 1998 Apr 15;91(8):3091
Abstract
Many aspects of Epstein-Barr virus (EBV) and tumor biology have been studied in Burkitt's lymphoma (BL)-derived cell lines. However, in tissue culture, patterns of gene expression and CpG [corrected] methylation often change and viral strain selection may occur. In this report, 10 cases of snap-frozen endemic BL tumors are characterized in terms of viral gene expression, promoter usage, methylation, and viral strain. EBNA1 and BamHI-A rightward transcripts (BART) were detected in 7 of 7 and LMP2A transcripts in 5 of 7 tumors with well-preserved RNA. Transcripts for the other EBNAs and for LMP1 were not detected in any tumor. These tumors differ from BL cell lines in that they lack a variety of lytic cycle transcripts. This pattern of viral gene expression in endemic BL is similar to that reported in peripheral blood mononuclear cells (PBMCs) from healthy EBV-seropositive individuals. EBNA1 transcripts originated from the Q promoter (Qp) but not C, W, or F promoters that drive transcription of EBNA1 in other circumstances. Whereas Cp has been previously shown to be entirely CpG methylated in BL, bisulfite genomic sequencing showed virtually no methylation in Qp. Type-A EBV was detected in 6 of 10 and type B in 4 of 10 cases. A previously reported 30bp deletion variant in the carboxyl terminal of LMP1 gene was detected in 5 of 10 cases. The association with both A and B strains contrasts with EBV-associated Hodgkin's disease, nasopharyngeal carcinoma, and post-transplant lymphoproliferative disease, which are much more consistently associated with A strain virus.
Similar articles
-
Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts.J Virol. 1992 May;66(5):2689-97. doi: 10.1128/JVI.66.5.2689-2697.1992. J Virol. 1992. PMID: 1313894 Free PMC article.
-
Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells.J Exp Med. 1993 Feb 1;177(2):339-49. doi: 10.1084/jem.177.2.339. J Exp Med. 1993. PMID: 8381153 Free PMC article.
-
Expression of Epstein-Barr virus-gene products in Burkitt's lymphoma in Northeast Brazil.Blood. 1996 Jun 15;87(12):5279-86. Blood. 1996. PMID: 8652843
-
Host cell-dependent expression of latent Epstein-Barr virus genomes: regulation by DNA methylation.Adv Cancer Res. 2003;89:133-56. doi: 10.1016/s0065-230x(03)01004-2. Adv Cancer Res. 2003. PMID: 14587872 Review.
-
Epigenetic regulation of latent Epstein-Barr virus promoters.Biochim Biophys Acta. 2010 Mar-Apr;1799(3-4):228-35. doi: 10.1016/j.bbagrm.2009.10.005. Epub 2009 Oct 22. Biochim Biophys Acta. 2010. PMID: 19853674 Review.
Cited by
-
Epstein-Barr Virus-Induced Epigenetic Pathogenesis of Viral-Associated Lymphoepithelioma-Like Carcinomas and Natural Killer/T-Cell Lymphomas.Pathogens. 2018 Jul 18;7(3):63. doi: 10.3390/pathogens7030063. Pathogens. 2018. PMID: 30022006 Free PMC article. Review.
-
Spleen Tyrosine Kinase Inhibitor TAK-659 Prevents Splenomegaly and Tumor Development in a Murine Model of Epstein-Barr Virus-Associated Lymphoma.mSphere. 2018 Aug 22;3(4):e00378-18. doi: 10.1128/mSphereDirect.00378-18. mSphere. 2018. PMID: 30135222 Free PMC article.
-
The latency pattern of Epstein-Barr virus infection and viral IL-10 expression in cutaneous natural killer/T-cell lymphomas.Br J Cancer. 2001 Apr 6;84(7):920-5. doi: 10.1054/bjoc.2000.1687. Br J Cancer. 2001. PMID: 11286472 Free PMC article.
-
NF-κB as a target for oncogenic viruses.Curr Top Microbiol Immunol. 2011;349:197-244. doi: 10.1007/82_2010_108. Curr Top Microbiol Immunol. 2011. PMID: 20845110 Free PMC article. Review.
-
Methionine metabolism controls the B cell EBV epigenome and viral latency.Cell Metab. 2022 Sep 6;34(9):1280-1297.e9. doi: 10.1016/j.cmet.2022.08.008. Cell Metab. 2022. PMID: 36070681 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous